Jennifer David, DO
Dermatology · Greensboro, NCNPI 1740571496
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 56.8% of the total. Reporting peaked in 2024 at $15,108 and has fallen 54.8% since, to $6,828 in 2025. Among dermatology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 579 payments — averaging $59.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$20K
- AbbVie$4K
- E.r. Squibb & Sons, L.L.C.$2K
- Johnson & Johnson$2K
- Sanofi$910
- Lilly USA, LLC$761
- plus $6K from 26 others
What the payments were for
- Consulting fees$19,96258%
- Travel & lodging$1,2254%
- Food & beverage$12,84137%
- Education$4851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 50 | $19,613 |
| AbbVie(2 entities) | 108 | $3,728 |
| E.r. Squibb & Sons, L.L.C. | 18 | $1,946 |
| Johnson & Johnson | 92 | $1,643 |
| Sanofi | 23 | $910 |
| Lilly USA, LLC | 44 | $761 |
| Sun Pharmaceutical Industries Inc. | 31 | $750 |
| Galderma Laboratories, L.p. | 29 | $687 |
| Hill Dermaceuticals, Inc. | 3 | $573 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 25 | $565 |
| Regeneron Healthcare Solutions, Inc. | 19 | $496 |
| Incyte Corporation | 17 | $493 |
| LEO Pharma Inc. | 29 | $376 |
| UCB, Inc. | 12 | $320 |
| Novartis | 10 | $257 |
| Almirall LLC | 13 | $240 |
| Organogenesis Inc. | 6 | $225 |
| Pfizer | 12 | $223 |
| Amgen | 11 | $209 |
| Journey Medical Corporation | 6 | $124 |
| Dermavant Sciences, Inc. | 4 | $83 |
| Encore Dermatology Inc. | 4 | $53 |
| Boehringer Ingelheim | 2 | $44 |
| EPI Health, LLC | 2 | $35 |
| Integra Lifesciences Corporation | 1 | $29 |
| Bristol Myers Squibb | 2 | $27 |
| Botanix SB Inc | 1 | $23 |
| Exact Sciences | 1 | $20 |
| Dermira, Inc. | 1 | $18 |
| Organon | 1 | $16 |
| Novo Nordisk | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,513 in reported general payments places this provider in the 90th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $77,801 |
| OtezlaApremilast | 12 | $59,110 |
| JubliaEfinaconazole | 15 | $14,471 |
| Tacrolimus | 39 | $8,090 |
| Clobetasol Propionate | 108 | $3,491 |
| Pimecrolimus | 11 | $1,815 |
| Doxycycline Hyclate | 55 | $1,189 |
| Triamcinolone Acetonide | 64 | $856 |
| Ketoconazole | 50 | $671 |
| Clindamycin Phosphate | 20 | $666 |
| Betamethasone Dipropionate | 11 | $451 |
| Hydrocortisone | 37 | $302 |
| Mupirocin | 33 | $206 |
| Minoxidil | 11 | $169 |
| ValacyclovirValacyclovir Hcl | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $209 | $59,11012 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $565 | $14,47115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 475 dermatology providers in North Carolina.
Other dermatology in Greensboro
- Arthur GrayGreensboro$18K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.